Janus Henderson Investors US’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Janus Henderson Investors US’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$77M	Sell	636,568 -14,914	-2%	-$1.83M	0.06%	350
2016 Q4	$72.8M	Sell	651,482 -123,271	-16%	-$14.8M	0.06%	364
2016 Q3	$103M	Sell	774,753 -44,771	-5%	-$4.28M	0.09%	295
2016 Q2	$75M	Sell	819,524 -277,847	-25%	-$23.4M	0.06%	351
2016 Q1	$79.2M	Buy	1,097,371 +194,798	+22%	+$10.7M	0.07%	329
2015 Q4	$62.7M	Buy	902,573 +69,458	+8%	+$5.66M	0.05%	363
2015 Q3	$76.1M	Buy	833,115 +97,684	+13%	+$10.9M	0.07%	327
2015 Q2	$90.3M	Buy	735,431 +180,682	+33%	+$20.5M	0.07%	329
2015 Q1	$50.6M	Buy	554,749 +142,473	+35%	+$11.6M	0.04%	448
2014 Q4	$27.9M	Buy	412,276 +49,194	+14%	+$3.59M	0.02%	549
2014 Q3	$29.4M	Buy	363,082 +18,150	+5%	+$1.61M	0.03%	520
2014 Q2	$37M	Buy	344,932 +79,187	+30%	+$5.51M	0.03%	470
2014 Q1	$15.8M	Buy	+265,745	New	+$15.8M	0.01%	588

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Janus Henderson Investors US's GWPH Position: Q1 2017 in Review

Janus Henderson Investors US reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 2.3% in Q1 2017, selling an estimated $1.83M and leaving 636,568 shares worth $77M. The position accounts for 0.06% of the portfolio, ranked #350.

Janus Henderson Investors US first reported a position in GWPH in Q1 2014 and has held it in 13 quarters since. The position peaked at $103M in Q3 2016. 179 funds tracked by Wall St. Rank hold GWPH as of Q1 2017.

Janus Henderson Investors US held 636,568 shares of GW Pharmaceuticals Plc American Depositary Shares worth $77M as of Q1 2017.
Janus Henderson Investors US sold 14,914 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2017, an estimated $1.83M.
GW Pharmaceuticals Plc American Depositary Shares made up 0.06% of Janus Henderson Investors US's portfolio in Q1 2017, its #350 holding.
Janus Henderson Investors US first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and has held it in 13 quarters since.
Janus Henderson Investors US's GW Pharmaceuticals Plc American Depositary Shares position peaked at $103M in Q3 2016.
179 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.